Approved for To treat hematopoietic stem cell transplant-associated thrombotic microangiopathy. 12.1 Mechanism of Action Narsoplimab-wuug inhibits MASP-2, the effector enzyme of the lectin pathway of the complement system, blocking lectin-dependent activation of complement component 3 (C3) and… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…
Loading full data from Know Your Drugs Institute…